Bionik Laboratories announced it postponed its annual shareholder meeting, which was scheduled to take place on September 14.
Bionik Laboratories (OTCQB:BNKL) announced it postponed its annual shareholder meeting, which was scheduled to take place on September 14.
As quoted in the press release:
Bionik will set a new record date and provide additional information with respect to the rescheduled annual meeting in a revised proxy statement to be filed with the SEC and distributed to stockholders as promptly as practicable.
As disclosed in the Company’s current report on Form 8-K filed with the Securities and Exchange Commission on September 11, 2017, among other things, Bionik increased the size of the Board from five to six members and appointed Remi Gaston Dreyfus to the Board effective as of September 1, 2017.